Comerica Bank’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.37M Buy
36,497
+24,573
+206% +$808K 0.01% 1331
2025
Q3
$329K Sell
11,924
-1,957
-14% -$67.4K ﹤0.01% 2098
2025
Q2
$439K Sell
13,881
-461
-3% -$14.8K ﹤0.01% 1936
2025
Q1
$476K Buy
14,342
+847
+6% +$30.4K ﹤0.01% 1868
2024
Q4
$464K Buy
13,495
+2,919
+28% +$100K ﹤0.01% 1907
2024
Q3
$423K Sell
10,576
-1,009
-9% -$35.4K ﹤0.01% 1958
2024
Q2
$350K Sell
11,585
-2,322
-17% -$69.8K ﹤0.01% 1998
2024
Q1
$467K Sell
13,907
-1,785
-11% -$57.3K ﹤0.01% 1904
2023
Q4
$507K Sell
15,692
-547
-3% -$15.3K ﹤0.01% 1851
2023
Q3
$532K Buy
+16,239
New +$564K ﹤0.01% 1765
2022
Q4
$874K Sell
17,826
-4,843
-21% -$266K 0.01% 1519
2022
Q3
$1.17M Buy
22,669
+3,075
+16% +$150K 0.01% 1385
2022
Q2
$1.03M Buy
19,594
+87
+0.4% +$3.92K 0.01% 1505
2022
Q1
$1.02M Buy
19,507
+710
+4% +$29K 0.01% 1580
2021
Q4
$641K Sell
18,797
-77,543
-80% -$3.09M ﹤0.01% 1770
2021
Q3
$3.93M Buy
+96,340
New +$3.1M 0.02% 826

Other funds holding HRMY

Comerica Bank's HRMY Position: Q4 2025 in Review

Comerica Bank increased its Harmony Biosciences (HRMY) stake by 206% in Q4 2025, buying an estimated $808K and bringing the position to 36,497 shares worth $1.37M. The position accounts for 0.01% of the portfolio, ranked #1331.

Comerica Bank first reported a position in HRMY in Q3 2021 and has held it in 16 quarters since. The position peaked at $3.93M in Q3 2021. 323 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

  • Comerica Bank held 36,497 shares of Harmony Biosciences worth $1.37M as of Q4 2025.
  • Comerica Bank bought 24,573 Harmony Biosciences shares in Q4 2025, an estimated $808K.
  • Harmony Biosciences made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1331 holding.
  • Comerica Bank first reported a position in Harmony Biosciences in Q3 2021 and has held it in 16 quarters since.
  • Comerica Bank's Harmony Biosciences position peaked at $3.93M in Q3 2021.
  • 323 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.